Ensysce Biosciences will host a symposium at the International Association for the Study of Pain 2024 World Congress on Pain on August 8, 2024 in Amsterdam, Netherlands. The Symposium entitled: ‘Severe Pain: A New Chapter for Safer Analgesics’ will feature Dr. Lars Arendt-Nielsen, Professor of Aalberg University of Medicine, Denmark, and Dr. William Schmidt, Chief Medical Officer of Ensysce Biosciences, two leading authorities on pain, pain treatment and analgesic drug development. Overall objectives of the session are to understand the current landscape for acute and severe pain treatment. Speakers will discuss current trends in severe pain associated with surgery and cancer progression, review drug use and abuse, and then examine the safety and effectiveness of PF614 and PF614-MPAR as indicated by clinical data results and how the leading agents are positioned for future clinical study.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENSC:
- Ensysce Biosciences discusses key themes from EPHMRA 2024
- Ensysce Biosciences announces partnership with Purisys for PF9001
- Ensysce Biosciences selects PF9001 to move into IND-enabling studies
- Ensysce Biosciences regains compliance with Nasdaq
- Ensysce Biosciences renews collaboration with Quotient Sciences